Dynasty Gene

BiotechnologySeries AShanghai, Chinadynastygene.com

Latest round

Series A

Last raised

Jun 2021

Total raised

$17M

Investors

4

About Dynasty Gene

Based in Shanghai, China and established in 2018, Dynasty Gene is a biotechnology company that focuses on the research and development of synthetic biology. In 2019, the company has established a new production and R&D base in Shanghai. Dr. Mancang Zhang, he company's co-founder and CTO, worked in Agilent, Twist, and ABI. The company engages in the research and development of high-throughput DNA synthesis technology. Its main products include NGS reagents, probe Panel and automatic sample preparation workstation, etc. Automatic sample preparation workstation can automatically process and test samples.

Who invested in Dynasty Gene

4 investors across 3 rounds

See all investors in Dynasty Gene

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 5, 2021

    Amount

    $16M

    Investors

    Locked

  2. Series A

    Aug 15, 2019

    Amount

    Undisclosed

    Investors

    Locked

  3. Angel

    Nov 1, 2018

    Amount

    $1.7M

    Investors

    Locked

Questions about Dynasty Gene

Who invested in Dynasty Gene?

Dynasty Gene has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dynasty Gene raised?

Dynasty Gene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Dynasty Gene last raise money?

Dynasty Gene's most recent round on record is a Series A, in Jun 2021.

What does Dynasty Gene do?

Based in Shanghai, China and established in 2018, Dynasty Gene is a biotechnology company that focuses on the research and development of synthetic biology.

Where is Dynasty Gene headquartered?

Dynasty Gene is headquartered in Shanghai, China.

Which VCs invest in companies like Dynasty Gene?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Dynasty Gene's stage. Their profiles are linked below.

Raising like Dynasty Gene? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.